细化炎性肌病的发病率与特征:一项使用2017年欧洲抗风湿病联盟/美国风湿病学会分类标准的四源捕获-再捕获调查
研究在法国阿尔萨斯200万人口区域,利用四源捕获-再捕获法及2017年EULAR/ACR分类标准,于2006年1月1日至2013年1月1日识别106例炎性肌病患者,估算发病率为每年每百万居民8.22例(95%CI 6.76-9.69),未观察到时空异质性,且除皮肌炎皮疹外的肌肉外表现常见。
要点
- 四源捕获-再捕获法估算炎性肌病发病率为8.22例/百万人年(95%CI 6.76-9.69)。
- 研究期间未观察到发病率的空间或时间异质性。
- 除皮肌炎皮疹外,肌肉外表现被频繁记录。
核心结论
- 严格的方法学提供了炎性肌病发病率的准确估计,并在基于人群的队列中证实了炎性肌病的全身性本质。
研究设计与样本
- 研究在法国阿尔萨斯(人口200万、医疗可及性良好且设有认证的炎性肌病转诊中心)进行,纳入2006年1月1日至2013年1月1日期间符合2017年EULAR/ACR分类标准的居住于该地区的患者,从全科医生和社区专科医生、公立和私立医院记录、公立和私立实验室、病理科档案四个来源获取临床数据,并使用捕获-再捕获分析校正可能不完全的病例确认,研究发病率的空间和时间分布并评估全身表现。
主要发现
- 审查1742例潜在病例后识别出106例炎性肌病患者。
- 对数线性模型显示估计有14.9例额外漏诊病例。
- 炎性肌病发病率为每年每百万居民8.22例新发病例(95%CI 6.76-9.69)。
- 未观察到空间或时间异质性。
- 除皮肌炎皮疹外的肌肉外表现被频繁记录。
关键数值与推荐
- 使用2017年EULAR/ACR炎性肌病分类标准。
- 捕获-再捕获分析估算额外漏诊14.9例,校正后发病率为8.22例/百万人年(95%CI 6.76-9.69)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Inflammatory myopathies (IM), characterized by muscle inflammation and weakness, are rare systemic diseases. Our previous study estimated an IM incidence rate of 7.98 cases per million people per year (95% confidence interval 7.38-8.66) and highlighted important variations that were likely because of methodologic issues rather than true epidemiologic differences. In this study, we aimed to refine the incidence of IM, using the 2017 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria for IM and a quadruple-source capture-recapture method during a 6-year period in Alsace, France, a region with a population of 2 million having benefits of good access to health care and accredited IM referral centers. METHODS: Clinical data of potential IM patients were obtained from 4 sources (general practitioners and community specialists, public and private hospital records, public and private laboratories, and archives from the pathology department). Patients residing in Alsace and who fulfilled the 2017 EULAR/ACR criteria for IM between January 1, 2006, and January 1, 2013, were included. We corrected potentially incomplete ascertainment of cases with capture-recapture analyses. We studied both spatial and temporal distributions of incidence of IM. We also assessed systemic manifestations of the disease. RESULTS: Our review of 1,742 potential cases identified 106 patients with IM. No spatial or temporal heterogeneity was observed. Use of log-linear models showed an estimated 14.9 additional missed cases. Thus, the incidence rate of IM was 8.22 new cases per million inhabitants per year (95% confidence interval 6.76-9.69). Extramuscular manifestations other than dermatomyositis rash were frequently recorded. CONCLUSION: The stringent methodology used in our study provides an accurate estimation of the incidence of IM. This study also demonstrates, in a population-based cohort, the systemic nature of IM.
引用
- Debrut L, Giannini M, Klein D, et al. Refining Incidence and Characteristics of Inflammatory Myopathies: A Quadruple-Source Capture-Recapture Survey Using the 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria. Arthritis Rheumatol. 2023. PMID: 37192377. doi:10.1002/art.42561
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。